Mizoribine as a safe and effective combined maintenance therapy with prednisolone for anti-neutrophil cytoplasmic antibody-associated vasculitis in a hemodialysis patient-Reference-Cited by-同舟云学术

Mizoribine as a safe and effective combined maintenance therapy with prednisolone for anti-neutrophil cytoplasmic antibody-associated vasculitis in a hemodialysis patient

Published:2013-01-30 Issue:2 Volume:2 Page:139-143
ISSN:2192-4449
Container-title:CEN Case Reports
language:en
Short-container-title:CEN Case Rep

Author:

Nakamura Gen,Homma Noriyuki,Sakamaki Yuichi,Toyama Mio,Unno Megumi,Kuroda Takeshi,Narita Ichiei

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

http://link.springer.com/content/pdf/10.1007/s13730-012-0050-1

Reference25 articles.

1. Lapraik C, Watts R, Bacon P, Carruthers D, Chakravarty K, D’Cruz D, et al. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology. 2007;46:1615–6.

2. Mukhtyar C, Guillevin L, Cid MC, Dasqupta B, de Groot K, Gross W, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68:310–7.

3. Mizuno K, Tsujino M, Takada M, Hayashi M, Atsumi K, Matsuda T. Studies on bredinin. I. Isolation, characterization and biological properties. J Antibiot (Tokyo). 1974;27:775–84.

4. Ishikawa H. Mizolibine and mycophenolate mofetil. Curr Med Chem. 1999;6:575–97.

5. Gerber DA, Bonham CA, Thomson AW. Immunosuppressive agents: recent development in molecular action and clinical application. Transplant Proc. 1998;30:1573–9.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coexistence of antineutrophil cytoplasmic antibody-associated vasculitis and membranous nephropathy: a case report;Annals of Palliative Medicine;2020-10

2. A case of anti-neutrophil cytoplasmic antibody-associated vasculitis with anti-glomerular basement membrane antibodies that was successfully treated with mizoribine as a safe and effective remission maintenance therapy with prednisolone and plasma exchange;CEN Case Reports;2019-10-14